edoc

Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients : data from the INC-EU Prospective Observational European Neutropenia Study

Schwenkglenks, Matthias and Pettengell, Ruth and Jackisch, Christian and Paridaens, Robert and Constenla, Manuel and Bosly, André and Szucs, Thomas D. and Leonard, Robert. (2011) Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients : data from the INC-EU Prospective Observational European Neutropenia Study. Supportive care in cancer, Vol. 19, H. 4. pp. 483-490.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6005411

Downloads: Statistics Overview

Abstract

Chemotherapy-induced neutropenia (CIN) places patients at risk of life-threatening infections. While reduction of chemotherapy dose or delay of the subsequent treatment cycle and, consequently, reduction of relative dose intensity (RDI) may limit myelotoxicity, these actions can also impact adversely on treatment outcome and should be avoided in adjuvant settings.
Faculties and Departments:03 Faculty of Medicine > Departement Public Health > Pharmazeutische Medizin ECPM > Pharmazeutische Medizin (Szucs)
UniBasel Contributors:Schwenkglenks, Matthias
Item Type:Article, refereed
Article Subtype:Research Article
Publisher:Springer
ISSN:1433-7339
Note:Publication type according to Uni Basel Research Database: Journal article
Identification Number:
Last Modified:27 Feb 2014 15:45
Deposited On:27 Feb 2014 15:45

Repository Staff Only: item control page